BiotechTube
Innovex Biosciences

Innovex Biosciences

Cambridge, United States· Est.
innovexbio.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $3.5M

Overview

Innovex Biosciences is a private, commercial-stage biotech tools company providing a suite of specialized reagents for immunohistochemistry and related assays. Its flagship technology, UNI-TRIEVE, offers a simple, low-temperature antigen retrieval method that prevents tissue damage, while its STAT-Q kits enable rapid, background-free staining in under an hour. The company targets the life sciences research and diagnostic pathology markets with products manufactured in the USA, emphasizing ease of use, reliability, and improved assay performance for both human and animal tissues.

Antibodies

Technology Platform

A suite of technologies for immunohistochemistry (IHC) and immunoassays, centered on the UNI-TRIEVE low-temperature antigen retrieval system. This is supported by proprietary blocking reagents (Fc Receptors Blocker, Background Buster) and integrated into rapid, background-free staining kits (STAT-Q, 1-Step Polymer) for human and animal tissues.

Funding History

1
Total raised:$3.5M
Seed$3.5M

Opportunities

The growing IHC market in research and diagnostics, especially for complex samples like xenografts, presents a significant opportunity.
Innovex's gentle, rapid, and background-free solutions address key lab pain points, positioning it to gain share from traditional, harsher methods.
The focus on the preclinical animal research market is a specific, high-growth niche.

Risk Factors

Intense competition from large, established life science tools companies poses a major threat.
Achieving widespread protocol adoption and clinical validation against standard methods is a significant hurdle.
As a small private company, limited resources for sales, marketing, and R&D could constrain growth.

Competitive Landscape

Innovex competes in the crowded IHC reagents and kits market dominated by giants like Agilent, Roche, and Thermo Fisher. Its differentiation is based on a unique low-temperature retrieval method and rapid, background-free staining kits. It likely competes with other specialty reagent companies (e.g., Vector Laboratories, BioLegend) on specific product lines, but its integrated platform approach is a distinct competitive angle.

More companies in Biologics / Biosimilars →More companies in United States →